Outpatient infusion sepsis protocol and outcomes for patients with cancer.

11135 Background: Sepsis, a life-threatening organ dysfunction caused by infection, is a common oncologic emergency in adult cancer patients. Early sepsis detection and timely antibiotic administration can improve outcomes and reduce mortality. As more oncology treatments move to outpatient infusion centers, implementing sepsis screening in these settings can improve early detection and opportunity for intervention. As a result, we implemented a best practice alert (BPA) and protocol for the initial evaluation and managements of sepsis in an outpatient oncology infusion center. Methods: We performed a retrospective study from June 2022 – December 2024 comparing outcomes of patients who presented to the outpatient oncology infusion center at our institution pre- and post-implementation of our sepsis workflow. We collected the following data: BPA alerts that were activated, time to antibiotics, initial lactate drawn, repeat lactate draw, cultures collected prior to antibiotic administration, appropriate IV fluid (IVF) resuscitation, number of patients transferred to the emergency department (ED) vs. Direct Admission (DA), length of stay, and number of Intensive Care Unit (ICU) transfers. Results: Pre-implementation (June – December 2022), 102 oncology patients were admitted with sepsis from the infusion center. Average time to antibiotics was 6 hours (SD=6.95), 90% had blood cultures drawn prior to antibiotic administration, 85% had lactate drawn, 80% second lactate was drawn when initial lactate was >2, and 46% had appropriate IVF. Twenty-two percent were DA. Average LOS was 11 days (SD=9.18) and 14 patients required ICU stay. Post-implementation (June 2023 – June 2024), 118 patients were evaluated and treated for possible sepsis. Average time to antibiotics was 1.5 hours, 100% had blood cultures prior to antibiotics, 95% had initial lactate, 91% had second lactate drawn if initial was >2, 46% appropriate IVF. Thirty four percent of evaluated patients were managed as an outpatient. Of those admitted, 78% were DA. The average LOS was 6 days (SD=4.6), and 4 patients required ICU stay. Conclusions: The outpatient sepsis protocol improved early management and treatment of patients with suspected sepsis, also improving clinical outcomes. As a result of the new workflow, more patients were directly admitted to the hospital avoiding unnecessary ED utilization. Early management helped reduce severity of sepsis resulting in fewer ICU admissions and shorter length of stay in the hospital. These improvements demonstrate the protocol's effectiveness and potential for broader application in oncology settings. Additional evaluation is needed to determine the generalizability of the protocol as it is scaled across the health system.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.11135
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Outpatient infusion sepsis protocol and outcomes for patients with cancer.

Helen Evers-Hunt, Adam Binder, A. A. Miles, Valerie Pracilio Csik et al.
Journal of Clinical Oncology
Neutropenia and Cancer Infections
article

Outpatient infusion sepsis protocol and outcomes for patients with cancer.

Helen Evers-Hunt, Adam Binder, A. A. Miles, Valerie Pracilio Csik, Roseanne Dimarco
article en

Abstract

11135 Background: Sepsis, a life-threatening organ dysfunction caused by infection, is a common oncologic emergency in adult cancer patients. Early sepsis detection and timely antibiotic administration can improve outcomes and reduce mortality. As more oncology treatments move to outpatient infusion centers, implementing sepsis screening in these settings can improve early detection and opportunity for intervention. As a result, we implemented a best practice alert (BPA) and protocol for the initial evaluation and managements of sepsis in an outpatient oncology infusion center. Methods: We performed a retrospective study from June 2022 – December 2024 comparing outcomes of patients who presented to the outpatient oncology infusion center at our institution pre- and post-implementation of our sepsis workflow. We collected the following data: BPA alerts that were activated, time to antibiotics, initial lactate drawn, repeat lactate draw, cultures collected prior to antibiotic administration, appropriate IV fluid (IVF) resuscitation, number of patients transferred to the emergency department (ED) vs. Direct Admission (DA), length of stay, and number of Intensive Care Unit (ICU) transfers. Results: Pre-implementation (June – December 2022), 102 oncology patients were admitted with sepsis from the infusion center. Average time to antibiotics was 6 hours (SD=6.95), 90% had blood cultures drawn prior to antibiotic administration, 85% had lactate drawn, 80% second lactate was drawn when initial lactate was >2, and 46% had appropriate IVF. Twenty-two percent were DA. Average LOS was 11 days (SD=9.18) and 14 patients required ICU stay. Post-implementation (June 2023 – June 2024), 118 patients were evaluated and treated for possible sepsis. Average time to antibiotics was 1.5 hours, 100% had blood cultures prior to antibiotics, 95% had initial lactate, 91% had second lactate drawn if initial was >2, 46% appropriate IVF. Thirty four percent of evaluated patients were managed as an outpatient. Of those admitted, 78% were DA. The average LOS was 6 days (SD=4.6), and 4 patients required ICU stay. Conclusions: The outpatient sepsis protocol improved early management and treatment of patients with suspected sepsis, also improving clinical outcomes. As a result of the new workflow, more patients were directly admitted to the hospital avoiding unnecessary ED utilization. Early management helped reduce severity of sepsis resulting in fewer ICU admissions and shorter length of stay in the hospital. These improvements demonstrate the protocol's effectiveness and potential for broader application in oncology settings. Additional evaluation is needed to determine the generalizability of the protocol as it is scaled across the health system.

Journal of Clinical OncologyVol. 43(16_suppl)
Thomas Jefferson University (US), Thomas Jefferson University Hospital (US), Sidney Kimmel Cancer Center (US)
Openalex Percentile: Top 82%
Neutropenia and Cancer Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.